Clement D.
- Country
- France
- Department
- 1203: Oncologie Medicale
Research Overview
- Assessment of 18F-Fluoromisonidazole PET Hypoxia Imaging in Idiopathic Pulmonary Fibrosis: A Non-Randomized Proof-of-Concept Study
- Phase I/II Study of [225Ac]Ac-PSMA-R2 in Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer with/without Prior 177Lu-PSMA Therapy
- PEACE-6 Poor Responders: A randomized phase III trial evaluating the efficacy and safety of 177Lu-PSMA-617 in addition to Standard of Care (SoC) versus SoC alone in de novo metastatic hormone-sensitive prostate cancer (mHSPC) patients having a serum PSA level of ≥ 0.2 ng/mL at 6 to 8 months after systemic treatment initiation for mHSPC.
Data & Insights
Has run more than one trial at 6 of 49 partner sites.
Specializations
Prostate Cancer Research
The investigator specializes in advanced therapeutic approaches for metastatic prostate cancer, with particular focus on radioligand therapy applications. Their research encompasses both hormone-sensitive and castration-resistant disease states.
- PSMA-targeted therapies
- Metastatic disease management
- Systemic treatment approaches
Their work includes evaluating novel therapeutic compounds for patients with varying treatment histories.
Nuclear Medicine Imaging
The investigator conducts research in advanced imaging techniques, particularly focusing on PET/CT diagnostics and specialized tracers for various oncological conditions.
- Fluorocholine imaging
- Fluorodeoxyglucose studies
- Hypoxia imaging
Their imaging research extends to multiple cancer types and pulmonary conditions.
Multiple Myeloma Studies
The investigator explores comparative imaging methodologies for multiple myeloma detection and assessment, focusing on innovative diagnostic approaches.
- Lesion detection techniques
- Comparative imaging studies
- Diagnostic optimization
Their work aims to enhance the accuracy of disease detection and monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.